F 0582
Give residents notice of Medicaid/Medicare coverage and potential liability for services not covered.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review the facility failed to provide required written beneficiary notifications
(Skilled Nursing Facility Advance Beneficiary Notice Form Centers for Medicare and Medicaid Services
10055 [SNF ABN Form CMS-10055]) to three (Resident #7, Resident #68 and Resident # 83) of three
sampled residents.
Residents Affected - Few
Findings included:
On 2/11/21 at 9:30 a.m., written notices for Resident #7, Resident #68 and Resident # 83 were reviewed.
There was no documentary evidence of completed SNF ABN Form CMS-10055 for all three sampled
residents.
02/11/21 1:51 p.m., the Interim Executive Director, Staff A and the Director of Social Services, Staff B were
interviewed. Staff A and Staff B stated the facility had not been providing eligible residents copies of
completed SNF ABN Form CMS-10055. Both stated the facility had not been completing the documents.
Staff A stated the facility social workers had not been trained on the required beneficiary notice.
On 02/12/21 9:57 a.m., Staff B was interviewed. Staff B stated she was not familiar with the required SNF
ABN Form CMS-10055. Staff B stated since she started in May 2020, We have not been completing them
and therefore had not been informing eligible residents of what is covered and not covered by Medicare
Part A.
Review of the facility policy and procedure titled Advance Beneficiary Notice - ABN last revised 11/10/2015,
indicated, An ABN will be utilized to notify residents of the possibility that medicare will not pay for the
item(s) that are described on the form. The facility will place their name, address, and telephone number on
the top of the notice header; and may elect to include their logo. The form cannot otherwise be modified
other than the additional information that is required. Information added to the form must be in at least 12
font and legible. The form will be reviewed with the residents or authorized representatives .The facility will
give a completed copy of the ABN far enough in advance that the beneficiary or the representative has the
time to consider the options and make an informed choice .
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
105417
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105417
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/12/2021
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Aviata at the Bay
2916 Habana Way
Tampa, FL 33614
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0583
Keep residents' personal and medical records private and confidential.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and policy review the facility failed to ensure that the confidential medical
information for one (Resident # 109) of six residents reviewed during the facility task of Medication
Administration, was secured when he left the computer screen displaying Resident #109's record
unattended on his cart on multiple occasions during a medication pass.
Residents Affected - Few
Findings included:
During the evening medication pass of 02/11/21 at 4:45 p.m. Staff C, Registered Nurse (RN) stepped away
from his medication cart to verify that a glucometer was stored in Resident #109's room. Staff C, locked his
cart when he stepped away but neglected to lock the screen or close the computer that sits atop the cart
and displayed the confidential medical information for Resident # 109. Staff C returned to the cart and
proceeded to prepare his supplies when he noticed that he did not have any gloves, he locked the cart but
did not close the computer leaving the private confidential information pertaining to Resident #109's
medication in full view on the computer screen. Once Staff C, RN had gathered all the necessary supplies,
he locked his cart but did not close the computer, he entered Resident # 109's room. Staff C left the
computer screen displaying Resident # 109's private medical information. Several residents and other
employees were seen in the hallway. When he returned to the cart, he confirmed that the computer screen
should be closed to ensure the privacy of resident records when the cart was unattended. He confirmed
that education related to confidentiality of the medical record was provided to him during orientation. Staff C
stated, As a nurse, I know that this medical information is private and I should have locked the screen.
A request was made to the Director of Nursing (DON) and a Regional Clinical Resource for the policy
pertaining to ensuring that the private confidential information of the residents was not at risk during
medication administration, but review of the provided policy did not provide any additional information.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105417
If continuation sheet
Page 2 of 4
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105417
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/12/2021
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Aviata at the Bay
2916 Habana Way
Tampa, FL 33614
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observations, interviews and record review the facility failed to maintain drugs and biological's
used in the facility in a safe, secure, and orderly manner in three of five inspected medication carts and one
of two inspected medication storage rooms.
Findings include:
On 2/11/21 at 4:25 p.m., an observation of the second-floor low side medication cart was conducted with
Staff G, Registered Nurse (RN). The nurse was asked to open the narcotic drawer to verify the narcotic
count. Staff G opened the narcotic drawer without a key. Photographic evidence was obtained. The nurse
was asked how long the narcotic drawer had been broken and the lock propped with a straw. The nurse
stated it had been like that for a while maybe two years. In the top drawer of the medication cart, an Insulin
pen had no open date or expired date on the packaging or the pen. Photographic evidence obtained. A
second Insulin pen was observed to be expired (opened on 1/8 and expired on 2/6). Photographic evidence
obtained. An interview with Staff G was conducted. Staff G stated she was responsible for making sure all
medications in the cart were not expired and when Insulin was removed from the refrigerator and placed in
the cart it was the policy to date it with an open and an expire date.
On 2/11/21 at 4:45 p.m., an observation of the second-floor medication storage room was conducted with
Staff G. A small refrigerator located inside the storage room was opened for inspection by the nurse. Seven
vials of Lorazepam 2 mg/ml, a schedule II medication, in two bags were observed in a non-affixed small
metal box sitting on the shelf and able to be removed from the refrigerator for inspection. Photographic
evidence obtained. An interview with Staff G was conducted. The nurse stated the medications had always
been kept that way to her knowledge.
On 2/11/21 at 5:15 p.m., an observation of the second-floor high side medication cart was conducted with
Staff C, RN. In the top drawer of the medication cart an Insulin vial was observed with no open or expiration
date on the label or the bottle. Photographic evidence obtained. A second vial of Insulin was observed to be
expired (opened on 1/7, expired on 2/5). Photographic evidence obtained. A third vial of Insulin was
observed with no open or expiration date on the label or the bottle. Photographic evidence obtained. Loose
pills were observed in the second drawer of the medication cart. Photographic evidence obtained. In the
bottom drawer of the medication cart a large bag of Perforomist 20 mcg/2 ml with two stickers on the bag
stating REFRIGERATE. Photographic evidence obtained. An interview was conducted with Staff C. The
nurse indicated he was not aware of why the medication would be in the medication cart when it was
labeled to refrigerate. The nurse confirmed expired medications should not be in the medication cart and
should be disposed of. The nurse stated when Insulin was removed from the refrigerator, they were to label
it with an open date and an expiration date per policy.
On 2/12/21 at 12:50 p.m., an observation of the third-floor low side medication cart was conducted with
Staff H, RN. On the top drawer of the medication cart a vial of Insulin was observed to have no open or
expired date on the packaging or the vial. Photographic evidence obtained. An interview was conducted
with Staff H. The nurse confirmed that all Insulin was to be dated with an open date and an expired date
once removed from the refrigerator and placed in the medication cart according to policy.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105417
If continuation sheet
Page 3 of 4
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105417
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/12/2021
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Aviata at the Bay
2916 Habana Way
Tampa, FL 33614
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
On 2/12/21 at 2:21 p.m., a telephone interview was conducted with the facility Consulting Pharmacist. She
indicated the facility was to keep all Schedule II-V medications in a separate locked area and in a fixed
compartment that could not be removed. She indicated there were fixed drawers in some of the
refrigerators. The Consulting Pharmacist stated all Insulin were to be dated with an open date and an
expire date once it was removed from the refrigerator and stored in the medication carts. She stated the
Perforomist should also be dated once it was removed from the refrigerator to assure it did not expire.
A review of the facility policy entitled Storage and expiration dating of medications, biologicals, syringes,
and needles (revised 10/28/2019) indicated the following:
Applicability: This policy 5.3 sets for the procedures relating to storage and expiration dates of medications,
biological, syringes and needles.
Procedure:
2 Facility should ensure that medications and biologicals are stored in an orderly manner in cabinets,
drawers, carts, refrigerators/freezers of sufficient size to prevent crowding.
3.1 Facility should store Schedule II-V Controlled Substances, in a separate compartment within the locked
medication carts and should have a different key to access device
3.1.1 Store all drugs and biologicals in locked compartment, including the storage of Schedule II-V
medications in separately locked, permanently affixed compartments, permitting only authorized personnel
to have access.
5 Once any medication or biological package is opened, facility should follow manufacturer/supplier
guidelines with respect to expiration dates for opened medications. Facility staff should record the date
opened on the primary medication container when the medication has a shortened expiration date once
opened.
11 Facility should ensure that medications and biologicals are stored at their appropriate temperatures
according to the Untie States Pharmacopeia guideline for temperature ranges.
17 Facility should destroy or return all discontinued, outdated/expired, or deteriorated medication or
biologicals in accordance with Pharmacy return/destruction guidelines.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105417
If continuation sheet
Page 4 of 4